25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Laobaixing Pharmacy
Buy, Hold or Sell?

Let's analyze Laobaixing Pharmacy together

I guess you are interested in Laobaixing Pharmacy. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Laobaixing Pharmacy. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Laobaixing Pharmacy

I send you an email if I find something interesting about Laobaixing Pharmacy.

1. Quick Overview

1.1. Quick analysis of Laobaixing Pharmacy (30 sec.)










1.2. What can you expect buying and holding a share of Laobaixing Pharmacy? (30 sec.)

How much money do you get?

How much money do you get?
¥0.11
When do you have the money?
1 year
How often do you get paid?
97.5%

What is your share worth?

Current worth
¥9.86
Expected worth in 1 year
¥10.04
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
¥0.94
Return On Investment
4.5%

For what price can you sell your share?

Current Price per Share
¥20.76
Expected price per share
¥15.39 - ¥27.85
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Laobaixing Pharmacy (5 min.)




Live pricePrice per Share (EOD)
¥20.76
Intrinsic Value Per Share
¥-11.13 - ¥20.75
Total Value Per Share
¥-1.27 - ¥30.61

2.2. Growth of Laobaixing Pharmacy (5 min.)




Is Laobaixing Pharmacy growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$1b$37.1m3.6%

How much money is Laobaixing Pharmacy making?

Current yearPrevious yearGrowGrow %
Making money$32.3m$29.6m$2.7m8.4%
Net Profit Margin4.1%3.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Laobaixing Pharmacy (5 min.)




2.4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Laobaixing Pharmacy?

Welcome investor! Laobaixing Pharmacy's management wants to use your money to grow the business. In return you get a share of Laobaixing Pharmacy.

First you should know what it really means to hold a share of Laobaixing Pharmacy. And how you can make/lose money.

Speculation

The Price per Share of Laobaixing Pharmacy is ¥20.76. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Laobaixing Pharmacy.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Laobaixing Pharmacy, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥9.86. Based on the TTM, the Book Value Change Per Share is ¥0.04 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.19 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Laobaixing Pharmacy.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.2%0.040.2%0.040.2%0.030.2%0.030.1%
Usd Book Value Change Per Share-0.03-0.1%0.010.0%0.020.1%0.030.2%0.030.2%
Usd Dividend Per Share0.040.2%0.030.1%0.010.0%0.010.1%0.010.1%
Usd Total Gains Per Share0.010.1%0.030.2%0.030.1%0.050.2%0.050.2%
Usd Price Per Share2.59-3.65-4.92-7.00-6.94-
Price to Earnings Ratio19.23-21.91-33.42-57.96-84.77-
Price-to-Total Gains Ratio237.82-214.96-293.37-734.12-807.56-
Price to Book Ratio1.86-2.66-3.72-7.55-10.92-
Price-to-Total Gains Ratio237.82-214.96-293.37-734.12-807.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.923008
Number of shares342
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.01
Usd Book Value Change Per Share0.010.03
Usd Total Gains Per Share0.030.05
Gains per Quarter (342 shares)11.3016.70
Gains per Year (342 shares)45.2066.81
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
137935194857
27317803896124
31102612557143191
41463517076191258
51834321595239325
621952260114287392
725660305133334459
829369350152382526
932978395171430593
1036686440190478660

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%41.00.00.0100.0%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%13.07.00.065.0%29.011.00.072.5%29.011.01.070.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.01.097.5%40.00.01.097.6%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%37.03.00.092.5%38.03.00.092.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Laobaixing Pharmacy compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2110.045-571%0.162-230%0.248-185%0.246-186%
Book Value Per Share--9.8579.761+1%9.417+5%7.670+29%5.433+81%
Current Ratio--0.8520.851+0%0.864-1%0.858-1%0.558+53%
Debt To Asset Ratio--0.6440.651-1%0.659-2%0.640+1%0.587+10%
Debt To Equity Ratio--1.9812.030-2%2.099-6%1.9820%1.641+21%
Dividend Per Share--0.2880.190+52%0.038+661%0.099+192%0.083+249%
Eps--0.2390.302-21%0.277-14%0.246-3%0.179+33%
Free Cash Flow Per Share--0.0640.542-88%0.655-90%0.513-88%0.316-80%
Free Cash Flow To Equity Per Share--0.0640.542-88%0.168-62%0.344-81%0.379-83%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--20.752--------
Intrinsic Value_10Y_min---11.129--------
Intrinsic Value_1Y_max--2.385--------
Intrinsic Value_1Y_min--0.866--------
Intrinsic Value_3Y_max--6.932--------
Intrinsic Value_3Y_min--0.900--------
Intrinsic Value_5Y_max--11.200--------
Intrinsic Value_5Y_min---0.928--------
Market Cap15782395061.760+12%13957844354.64019734052020.600-29%26577674920.960-47%37807498075.160-63%37467262868.447-63%
Net Profit Margin--0.0340.041-18%0.039-13%0.043-21%0.046-27%
Operating Margin----0%0.068-100%0.055-100%0.036-100%
Operating Ratio--1.6061.600+0%1.6090%1.602+0%1.233+30%
Pb Ratio2.106+12%1.8632.660-30%3.716-50%7.546-75%10.922-83%
Pe Ratio21.745+12%19.23121.908-12%33.420-42%57.961-67%84.769-77%
Price Per Share20.760+12%18.36025.950-29%34.960-47%49.730-63%49.283-63%
Price To Free Cash Flow Ratio81.493+12%72.07227.253+164%20.636+249%39.461+83%76.848-6%
Price To Total Gains Ratio268.907+12%237.819214.963+11%293.368-19%734.117-68%807.562-71%
Quick Ratio--0.2000.200+0%0.207-3%0.204-2%0.239-16%
Return On Assets--0.0090.011-20%0.010-14%0.012-26%0.014-39%
Return On Equity--0.0270.034-21%0.032-16%0.036-26%0.038-29%
Total Gains Per Share--0.0770.235-67%0.200-61%0.347-78%0.329-77%
Usd Book Value--1055150012.2241045141646.525+1%1007993111.699+5%821039990.517+29%581601853.173+81%
Usd Book Value Change Per Share---0.0300.006-571%0.023-230%0.035-185%0.035-186%
Usd Book Value Per Share--1.3881.374+1%1.326+5%1.080+29%0.765+81%
Usd Dividend Per Share--0.0410.027+52%0.005+661%0.014+192%0.012+249%
Usd Eps--0.0340.043-21%0.039-14%0.035-3%0.025+33%
Usd Free Cash Flow--6817047.42458000338.387-88%70064411.226-90%54938414.911-88%33829632.957-80%
Usd Free Cash Flow Per Share--0.0090.076-88%0.092-90%0.072-88%0.044-80%
Usd Free Cash Flow To Equity Per Share--0.0090.076-88%0.024-62%0.048-81%0.053-83%
Usd Market Cap2222161224.696+12%1965264485.1332778554524.500-29%3742136628.871-47%5323295728.983-63%5275390611.877-63%
Usd Price Per Share2.923+12%2.5853.654-29%4.922-47%7.002-63%6.939-63%
Usd Profit--25547712.39732330570.659-21%29628076.826-14%26369074.716-3%19206615.120+33%
Usd Revenue--760394954.176794333459.990-4%774235051.850-2%628986654.025+21%438615003.246+73%
Usd Total Gains Per Share--0.0110.033-67%0.028-61%0.049-78%0.046-77%
 EOD+4 -4MRQTTM+13 -21YOY+11 -245Y+10 -2510Y+14 -21

3.3 Fundamental Score

Let's check the fundamental score of Laobaixing Pharmacy based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1521.745
Price to Book Ratio (EOD)Between0-12.106
Net Profit Margin (MRQ)Greater than00.034
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.200
Current Ratio (MRQ)Greater than10.852
Debt to Asset Ratio (MRQ)Less than10.644
Debt to Equity Ratio (MRQ)Less than11.981
Return on Equity (MRQ)Greater than0.150.027
Return on Assets (MRQ)Greater than0.050.009
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Laobaixing Pharmacy based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.781
Ma 20Greater thanMa 5017.130
Ma 50Greater thanMa 10015.620
Ma 100Greater thanMa 20016.771
OpenGreater thanClose19.800
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Laobaixing Pharmacy

LBX Pharmacy Chain Joint Stock Company operates pharmacy store chain in China. The company was formerly known as Laobaixing Pharmacy Chain Joint Stock Company. LBX Pharmacy Chain Joint Stock Company was founded in 2001 and is based in Changsha, China.

Fundamental data was last updated by Penke on 2024-10-31 16:51:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Laobaixing Pharmacy earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Laobaixing Pharmacy to the Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of 3.4% means that ¥0.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Laobaixing Pharmacy:

  • The MRQ is 3.4%. The company is making a profit. +1
  • The TTM is 4.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.4%TTM4.1%-0.7%
TTM4.1%YOY3.9%+0.2%
TTM4.1%5Y4.3%-0.2%
5Y4.3%10Y4.6%-0.3%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4%1.0%+2.4%
TTM4.1%0.7%+3.4%
YOY3.9%1.0%+2.9%
5Y4.3%1.6%+2.7%
10Y4.6%1.5%+3.1%
4.3.1.2. Return on Assets

Shows how efficient Laobaixing Pharmacy is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Laobaixing Pharmacy to the Pharmaceutical Retailers industry mean.
  • 0.9% Return on Assets means that Laobaixing Pharmacy generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Laobaixing Pharmacy:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.9%TTM1.1%-0.2%
TTM1.1%YOY1.0%+0.1%
TTM1.1%5Y1.2%-0.1%
5Y1.2%10Y1.4%-0.2%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%0.4%+0.5%
TTM1.1%0.4%+0.7%
YOY1.0%0.3%+0.7%
5Y1.2%0.3%+0.9%
10Y1.4%0.3%+1.1%
4.3.1.3. Return on Equity

Shows how efficient Laobaixing Pharmacy is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Laobaixing Pharmacy to the Pharmaceutical Retailers industry mean.
  • 2.7% Return on Equity means Laobaixing Pharmacy generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Laobaixing Pharmacy:

  • The MRQ is 2.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM3.4%-0.7%
TTM3.4%YOY3.2%+0.2%
TTM3.4%5Y3.6%-0.2%
5Y3.6%10Y3.8%-0.2%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7%1.4%+1.3%
TTM3.4%1.0%+2.4%
YOY3.2%1.6%+1.6%
5Y3.6%1.8%+1.8%
10Y3.8%0.8%+3.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Laobaixing Pharmacy.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Laobaixing Pharmacy is operating .

  • Measures how much profit Laobaixing Pharmacy makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Laobaixing Pharmacy to the Pharmaceutical Retailers industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Laobaixing Pharmacy:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY6.8%-6.8%
TTM-5Y5.5%-5.5%
5Y5.5%10Y3.6%+1.9%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.7%-2.7%
TTM-1.4%-1.4%
YOY6.8%1.5%+5.3%
5Y5.5%1.4%+4.1%
10Y3.6%1.3%+2.3%
4.3.2.2. Operating Ratio

Measures how efficient Laobaixing Pharmacy is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 1.61 means that the operating costs are ¥1.61 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Laobaixing Pharmacy:

  • The MRQ is 1.606. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.600. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.606TTM1.600+0.007
TTM1.600YOY1.609-0.009
TTM1.6005Y1.602-0.003
5Y1.60210Y1.233+0.369
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6061.493+0.113
TTM1.6001.246+0.354
YOY1.6091.147+0.462
5Y1.6021.174+0.428
10Y1.2331.185+0.048
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Laobaixing Pharmacy.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Laobaixing Pharmacy is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A Current Ratio of 0.85 means the company has ¥0.85 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Laobaixing Pharmacy:

  • The MRQ is 0.852. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.851. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.852TTM0.851+0.000
TTM0.851YOY0.864-0.012
TTM0.8515Y0.858-0.006
5Y0.85810Y0.558+0.300
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8521.259-0.407
TTM0.8511.270-0.419
YOY0.8641.161-0.297
5Y0.8581.315-0.457
10Y0.5581.443-0.885
4.4.3.2. Quick Ratio

Measures if Laobaixing Pharmacy is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Laobaixing Pharmacy to the Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 0.20 means the company can pay off ¥0.20 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Laobaixing Pharmacy:

  • The MRQ is 0.200. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.200. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.200TTM0.200+0.000
TTM0.200YOY0.207-0.007
TTM0.2005Y0.204-0.004
5Y0.20410Y0.239-0.035
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2000.505-0.305
TTM0.2000.546-0.346
YOY0.2070.536-0.329
5Y0.2040.641-0.437
10Y0.2390.881-0.642
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Laobaixing Pharmacy.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Laobaixing Pharmacy assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Laobaixing Pharmacy to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.64 means that Laobaixing Pharmacy assets are financed with 64.4% credit (debt) and the remaining percentage (100% - 64.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Laobaixing Pharmacy:

  • The MRQ is 0.644. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.651. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.644TTM0.651-0.007
TTM0.651YOY0.659-0.008
TTM0.6515Y0.640+0.010
5Y0.64010Y0.587+0.053
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6440.638+0.006
TTM0.6510.6510.000
YOY0.6590.690-0.031
5Y0.6400.640+0.000
10Y0.5870.600-0.013
4.5.4.2. Debt to Equity Ratio

Measures if Laobaixing Pharmacy is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Laobaixing Pharmacy to the Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 198.1% means that company has ¥1.98 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Laobaixing Pharmacy:

  • The MRQ is 1.981. The company is just able to pay all its debts with equity.
  • The TTM is 2.030. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.981TTM2.030-0.049
TTM2.030YOY2.099-0.068
TTM2.0305Y1.982+0.049
5Y1.98210Y1.641+0.341
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9811.607+0.374
TTM2.0301.745+0.285
YOY2.0992.145-0.046
5Y1.9821.9820.000
10Y1.6411.661-0.020
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Laobaixing Pharmacy generates.

  • Above 15 is considered overpriced but always compare Laobaixing Pharmacy to the Pharmaceutical Retailers industry mean.
  • A PE ratio of 19.23 means the investor is paying ¥19.23 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Laobaixing Pharmacy:

  • The EOD is 21.745. Based on the earnings, the company is fair priced.
  • The MRQ is 19.231. Based on the earnings, the company is fair priced.
  • The TTM is 21.908. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD21.745MRQ19.231+2.514
MRQ19.231TTM21.908-2.677
TTM21.908YOY33.420-11.512
TTM21.9085Y57.961-36.053
5Y57.96110Y84.769-26.808
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD21.74510.142+11.603
MRQ19.23112.431+6.800
TTM21.9089.431+12.477
YOY33.42011.917+21.503
5Y57.9616.490+51.471
10Y84.76914.310+70.459
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Laobaixing Pharmacy:

  • The EOD is 81.493. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 72.072. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 27.253. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD81.493MRQ72.072+9.421
MRQ72.072TTM27.253+44.818
TTM27.253YOY20.636+6.617
TTM27.2535Y39.461-12.208
5Y39.46110Y76.848-37.387
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD81.4932.404+79.089
MRQ72.0722.425+69.647
TTM27.2532.438+24.815
YOY20.6363.326+17.310
5Y39.4612.868+36.593
10Y76.8480.118+76.730
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Laobaixing Pharmacy is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 1.86 means the investor is paying ¥1.86 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Laobaixing Pharmacy:

  • The EOD is 2.106. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.863. Based on the equity, the company is underpriced. +1
  • The TTM is 2.660. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.106MRQ1.863+0.243
MRQ1.863TTM2.660-0.798
TTM2.660YOY3.716-1.055
TTM2.6605Y7.546-4.886
5Y7.54610Y10.922-3.375
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD2.1061.134+0.972
MRQ1.8631.284+0.579
TTM2.6601.466+1.194
YOY3.7161.299+2.417
5Y7.5461.919+5.627
10Y10.9222.980+7.942
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets21,029,704
Total Liabilities13,535,741
Total Stockholder Equity6,832,734
 As reported
Total Liabilities 13,535,741
Total Stockholder Equity+ 6,832,734
Total Assets = 21,029,704

Assets

Total Assets21,029,704
Total Current Assets8,640,336
Long-term Assets12,389,369
Total Current Assets
Cash And Cash Equivalents 1,935,934
Short-term Investments 1,500
Net Receivables 2,032,093
Inventory 3,957,619
Other Current Assets 194,654
Total Current Assets  (as reported)8,640,336
Total Current Assets  (calculated)8,121,800
+/- 518,535
Long-term Assets
Property Plant Equipment 4,381,429
Goodwill 5,835,861
Intangible Assets 729,835
Long-term Assets Other 58,762
Long-term Assets  (as reported)12,389,369
Long-term Assets  (calculated)11,005,886
+/- 1,383,482

Liabilities & Shareholders' Equity

Total Current Liabilities10,146,459
Long-term Liabilities3,389,282
Total Stockholder Equity6,832,734
Total Current Liabilities
Short Long Term Debt 1,188,471
Accounts payable 6,201,695
Other Current Liabilities 39,911
Total Current Liabilities  (as reported)10,146,459
Total Current Liabilities  (calculated)7,430,076
+/- 2,716,383
Long-term Liabilities
Long term Debt 1,428,338
Capital Lease Obligations Min Short Term Debt1,912,878
Long-term Liabilities  (as reported)3,389,282
Long-term Liabilities  (calculated)3,341,216
+/- 48,066
Total Stockholder Equity
Retained Earnings 3,803,825
Total Stockholder Equity (as reported)6,832,734
Total Stockholder Equity (calculated)3,803,825
+/- 3,028,909
Other
Capital Stock760,231
Common Stock Shares Outstanding 760,231
Net Debt 680,874
Net Invested Capital 9,449,543
Net Working Capital -1,506,123
Property Plant and Equipment Gross 4,381,429



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-03-312013-12-312012-12-31
> Total Assets 
1,615,311
2,179,689
0
2,448,458
2,529,677
2,552,842
3,314,271
3,578,567
3,800,577
4,136,248
4,552,767
4,744,230
4,909,690
5,028,825
5,227,068
5,528,946
6,698,891
7,138,998
7,285,164
7,699,605
8,484,775
9,004,079
9,449,418
9,348,173
9,924,306
10,728,922
10,794,713
10,849,916
11,284,109
13,941,517
14,030,832
14,813,281
16,958,086
18,446,687
19,818,636
20,268,370
21,397,333
21,293,749
20,991,474
21,325,004
21,231,000
21,371,555
21,029,704
21,029,70421,371,55521,231,00021,325,00420,991,47421,293,74921,397,33320,268,37019,818,63618,446,68716,958,08614,813,28114,030,83213,941,51711,284,10910,849,91610,794,71310,728,9229,924,3069,348,1739,449,4189,004,0798,484,7757,699,6057,285,1647,138,9986,698,8915,528,9465,227,0685,028,8254,909,6904,744,2304,552,7674,136,2483,800,5773,578,5673,314,2712,552,8422,529,6772,448,45802,179,6891,615,311
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,167,468
4,156,080
4,311,042
4,664,153
5,006,372
4,797,776
5,075,821
5,731,125
5,610,393
5,416,348
5,634,674
5,262,860
5,258,125
5,520,897
6,228,151
7,328,761
7,444,031
7,844,693
9,463,131
9,150,791
8,919,086
8,939,207
9,129,881
9,195,201
8,640,336
8,640,3369,195,2019,129,8818,939,2078,919,0869,150,7919,463,1317,844,6937,444,0317,328,7616,228,1515,520,8975,258,1255,262,8605,634,6745,416,3485,610,3935,731,1255,075,8214,797,7765,006,3724,664,1534,311,0424,156,0804,167,468000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,166,753
1,069,594
1,118,199
1,187,601
1,554,151
1,327,867
1,385,944
1,397,882
1,278,756
1,027,075
1,372,222
1,043,666
1,020,052
967,874
1,408,875
2,393,268
2,030,521
2,343,695
2,410,922
2,363,580
2,230,870
1,950,605
1,974,985
2,018,447
1,935,934
1,935,9342,018,4471,974,9851,950,6052,230,8702,363,5802,410,9222,343,6952,030,5212,393,2681,408,875967,8741,020,0521,043,6661,372,2221,027,0751,278,7561,397,8821,385,9441,327,8671,554,1511,187,6011,118,1991,069,5941,166,753000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,734
0
7,000
0
13,120
21,000
21,500
23,800
25,900
3,000
3,000
3,000
3,000
3,000
3,000
3,000
3,000
3,000
3,000
3,000
1,500
1,500
1,500
1,5001,5001,5003,0003,0003,0003,0003,0003,0003,0003,0003,0003,0003,00025,90023,80021,50021,00013,12007,000017,73400000000000000000000
       Net Receivables 
229,505
281,962
0
298,589
319,929
351,532
323,972
429,692
430,632
538,362
533,509
614,465
584,708
673,581
707,388
659,434
808,203
910,558
886,817
925,619
969,346
1,030,250
1,014,842
961,828
1,089,684
1,159,437
1,166,110
1,285,093
1,223,574
1,487,407
1,405,221
1,386,022
1,761,382
1,833,451
1,881,255
1,990,999
2,250,860
2,150,420
2,053,592
2,011,609
2,223,517
2,168,665
2,032,093
2,032,0932,168,6652,223,5172,011,6092,053,5922,150,4202,250,8601,990,9991,881,2551,833,4511,761,3821,386,0221,405,2211,487,4071,223,5741,285,0931,166,1101,159,4371,089,684961,8281,014,8421,030,250969,346925,619886,817910,558808,203659,434707,388673,581584,708614,465533,509538,362430,632429,692323,972351,532319,929298,5890281,962229,505
       Other Current Assets 
102,058
145,512
0
164,177
156,142
129,220
189,896
315,152
199,074
227,588
236,934
252,863
313,148
253,293
294,902
325,831
487,093
399,722
524,575
563,016
157,680
97,269
100,283
98,725
517,732
861,700
646,473
784,791
619,566
203,958
282,154
440,925
318,524
306,803
416,341
306,538
840,967
480,843
562,389
182,016
197,262
203,925
194,654
194,654203,925197,262182,016562,389480,843840,967306,538416,341306,803318,524440,925282,154203,958619,566784,791646,473861,700517,73298,725100,28397,269157,680563,016524,575399,722487,093325,831294,902253,293313,148252,863236,934227,588199,074315,152189,896129,220156,142164,1770145,512102,058
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,339,926
4,443,047
4,550,396
4,848,485
4,997,797
5,184,320
5,433,568
5,649,435
8,678,657
8,772,707
9,292,384
10,729,935
11,117,926
12,374,605
12,423,678
11,934,202
12,142,959
12,072,388
12,385,797
12,101,119
12,176,354
12,389,369
12,389,36912,176,35412,101,11912,385,79712,072,38812,142,95911,934,20212,423,67812,374,60511,117,92610,729,9359,292,3848,772,7078,678,6575,649,4355,433,5685,184,3204,997,7974,848,4854,550,3964,443,0474,339,926000000000000000000000
       Property Plant Equipment 
133,925
170,955
0
182,917
197,132
198,335
193,308
198,548
212,119
219,020
244,449
230,949
268,776
378,490
395,177
436,555
433,813
465,473
557,859
664,167
807,392
861,103
951,755
984,041
993,247
1,008,049
991,877
1,011,747
1,080,638
3,417,610
3,495,845
3,467,503
4,671,459
4,562,826
4,819,381
4,839,397
4,173,888
4,331,719
4,350,421
4,539,690
4,140,778
4,218,445
4,381,429
4,381,4294,218,4454,140,7784,539,6904,350,4214,331,7194,173,8884,839,3974,819,3814,562,8264,671,4593,467,5033,495,8453,417,6101,080,6381,011,747991,8771,008,049993,247984,041951,755861,103807,392664,167557,859465,473433,813436,555395,177378,490268,776230,949244,449219,020212,119198,548193,308198,335197,132182,9170170,955133,925
       Goodwill 
0
0
0
378,778
399,192
399,192
416,368
590,564
760,468
760,468
1,202,484
1,202,484
1,221,233
1,221,233
1,221,233
1,221,233
1,521,121
1,684,160
1,786,335
1,806,209
1,987,441
2,006,308
2,070,039
2,130,173
2,324,135
2,474,241
2,598,105
2,689,708
2,808,804
3,450,333
3,484,859
3,638,225
3,695,011
3,707,315
5,269,061
5,272,986
5,492,648
5,499,948
5,740,068
5,809,948
5,835,861
5,841,361
5,835,861
5,835,8615,841,3615,835,8615,809,9485,740,0685,499,9485,492,6485,272,9865,269,0613,707,3153,695,0113,638,2253,484,8593,450,3332,808,8042,689,7082,598,1052,474,2412,324,1352,130,1732,070,0392,006,3081,987,4411,806,2091,786,3351,684,1601,521,1211,221,2331,221,2331,221,2331,221,2331,202,4841,202,484760,468760,468590,564416,368399,192399,192378,778000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,150
15,150
68,343
76,697
77,003
77,137
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000077,13777,00376,69768,34315,15015,150000000000000000000
       Intangible Assets 
148,372
416,805
0
475,106
496,764
495,887
513,217
687,205
880,882
879,680
1,368,521
1,372,738
1,402,123
1,400,080
1,399,070
1,415,547
1,809,768
1,981,271
294,601
293,562
339,674
338,472
193,572
733,153
435,192
440,996
447,822
460,916
432,930
428,324
435,102
452,088
466,317
476,532
493,402
486,643
599,982
590,213
586,691
628,700
746,982
732,175
729,835
729,835732,175746,982628,700586,691590,213599,982486,643493,402476,532466,317452,088435,102428,324432,930460,916447,822440,996435,192733,153193,572338,472339,674293,562294,6011,981,2711,809,7681,415,5471,399,0701,400,0801,402,1231,372,7381,368,521879,680880,882687,205513,217495,887496,764475,1060416,805148,372
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
507,336
24,332
31,212
48,143
35,747
86,604
1,092,247
42,298
56,045
14,015
359,849
110,698
571,743
92,972
156,748
24,800
79,889
73,769
82,845
51,289
39,708
58,762
58,76239,70851,28982,84573,76979,88924,800156,74892,972571,743110,698359,84914,01556,04542,2981,092,24786,60435,74748,14331,21224,332507,336000000000000000000000
> Total Liabilities 
882,718
1,263,230
0
1,416,794
1,444,036
1,391,650
1,101,210
1,373,459
1,508,582
1,755,890
2,145,836
2,474,152
2,964,355
2,960,526
3,147,704
3,360,838
3,597,779
3,896,882
4,208,278
4,499,930
5,115,443
5,420,214
5,726,737
5,636,796
6,049,575
6,613,927
6,215,726
6,204,415
6,478,731
9,349,948
9,242,267
10,031,652
12,179,192
11,685,760
12,953,882
13,419,976
14,299,610
13,961,361
13,633,812
14,072,911
13,941,960
13,715,128
13,535,741
13,535,74113,715,12813,941,96014,072,91113,633,81213,961,36114,299,61013,419,97612,953,88211,685,76012,179,19210,031,6529,242,2679,349,9486,478,7316,204,4156,215,7266,613,9276,049,5755,636,7965,726,7375,420,2145,115,4434,499,9304,208,2783,896,8823,597,7793,360,8383,147,7042,960,5262,964,3552,474,1522,145,8361,755,8901,508,5821,373,4591,101,2101,391,6501,444,0361,416,79401,263,230882,718
   > Total Current Liabilities 
880,343
1,228,350
0
1,334,222
1,363,313
1,311,927
1,078,830
1,355,829
1,492,494
1,740,212
2,130,565
1,668,046
2,140,851
2,136,366
2,212,200
2,421,330
2,651,005
2,945,698
3,262,837
3,551,274
4,945,869
5,255,821
5,291,118
5,115,613
5,347,946
5,880,465
5,845,699
5,993,102
6,291,282
7,818,189
6,730,847
7,007,655
8,612,820
8,189,996
9,159,062
9,227,542
10,846,500
10,721,083
10,150,859
10,577,075
11,155,093
10,325,787
10,146,459
10,146,45910,325,78711,155,09310,577,07510,150,85910,721,08310,846,5009,227,5429,159,0628,189,9968,612,8207,007,6556,730,8477,818,1896,291,2825,993,1025,845,6995,880,4655,347,9465,115,6135,291,1185,255,8214,945,8693,551,2743,262,8372,945,6982,651,0052,421,3302,212,2002,136,3662,140,8511,668,0462,130,5651,740,2121,492,4941,355,8291,078,8301,311,9271,363,3131,334,22201,228,350880,343
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,160
11,960
806,460
818,860
826,820
746,820
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000746,820826,820818,860806,46011,96011,160000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,160
11,960
806,460
818,860
826,820
746,820
1,077,828
1,531,675
1,572,375
1,369,064
1,158,326
1,943,889
1,059,217
1,215,831
1,616,080
1,265,506
1,090,661
1,162,807
766,211
569,682
769,295
898,665
799,755
632,230
1,188,471
1,188,471632,230799,755898,665769,295569,682766,2111,162,8071,090,6611,265,5061,616,0801,215,8311,059,2171,943,8891,158,3261,369,0641,572,3751,531,6751,077,828746,820826,820818,860806,46011,96011,160000000000000000000
       Accounts payable 
517,919
689,859
0
810,286
811,046
836,184
812,906
920,759
946,566
1,108,172
1,120,256
1,239,911
1,247,107
1,267,530
1,328,131
1,396,284
1,716,509
1,994,822
2,086,936
2,194,976
2,485,717
2,871,309
2,759,262
3,488,371
3,265,804
3,450,238
3,378,273
3,627,228
4,108,851
4,272,172
3,949,337
4,440,450
4,914,942
5,002,041
5,434,026
5,802,379
6,947,983
6,956,462
6,399,940
6,624,800
6,995,017
6,919,115
6,201,695
6,201,6956,919,1156,995,0176,624,8006,399,9406,956,4626,947,9835,802,3795,434,0265,002,0414,914,9424,440,4503,949,3374,272,1724,108,8513,627,2283,378,2733,450,2383,265,8043,488,3712,759,2622,871,3092,485,7172,194,9762,086,9361,994,8221,716,5091,396,2841,328,1311,267,5301,247,1071,239,9111,120,2561,108,172946,566920,759812,906836,184811,046810,2860689,859517,919
       Other Current Liabilities 
172,424
223,672
0
227,863
263,954
219,700
265,924
435,070
445,928
392,040
582,609
411,634
413,244
396,636
405,869
446,846
749,136
772,416
539,921
534,403
553,292
820,879
905,999
112,177
603,601
693,865
556,175
763,379
589,584
1,404,250
730,839
929,056
778,499
942,677
1,561,457
1,155,646
1,058,465
2,788,828
1,066,273
39,469
36,802
38,263
39,911
39,91138,26336,80239,4691,066,2732,788,8281,058,4651,155,6461,561,457942,677778,499929,056730,8391,404,250589,584763,379556,175693,865603,601112,177905,999820,879553,292534,403539,921772,416749,136446,846405,869396,636413,244411,634582,609392,040445,928435,070265,924219,700263,954227,8630223,672172,424
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
164,394
435,619
521,183
701,629
733,462
370,027
211,313
187,449
1,531,759
2,511,420
3,023,998
3,566,372
3,495,764
3,794,821
4,192,434
3,453,110
3,240,278
3,482,953
3,495,836
2,786,867
3,389,341
3,389,282
3,389,2823,389,3412,786,8673,495,8363,482,9533,240,2783,453,1104,192,4343,794,8213,495,7643,566,3723,023,9982,511,4201,531,759187,449211,313370,027733,462701,629521,183435,619164,394000000000000000000000
       Other Liabilities 
0
18,939
0
7,319
7,634
7,634
7,849
3,099
2,038
1,890
1,742
1,848
7,961
8,898
8,014
11,931
36,344
40,328
61,739
64,516
85,874
78,954
81,625
78,767
52,875
81,306
88,527
85,313
69,449
71,432
65,238
58,760
65,940
65,858
60,504
58,924
0
51,129
50,977
0
0
0
0
000050,97751,129058,92460,50465,85865,94058,76065,23871,43269,44985,31388,52781,30652,87578,76781,62578,95485,87464,51661,73940,32836,34411,9318,0148,8987,9611,8481,7421,8902,0383,0997,8497,6347,6347,319018,9390
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
366,181
385,285
466,003
463,181
502,235
514,260
540,545
543,252
537,303
571,161
608,520
618,990
633,365
659,865
683,556
683,713
699,087
690,861
0
696,650
709,875
0
0
0
0
0000709,875696,6500690,861699,087683,713683,556659,865633,365618,990608,520571,161537,303543,252540,545514,260502,235463,181466,003385,285366,181000000000000000000
> Total Stockholder Equity
649,087
809,807
916,459
918,653
967,916
1,033,539
2,098,311
2,142,007
2,218,445
2,297,515
2,283,186
2,175,540
1,850,391
1,963,724
1,959,987
2,044,670
2,930,827
3,026,345
2,832,705
2,936,104
3,046,175
3,251,585
3,377,893
3,366,545
3,487,150
3,688,059
4,122,511
4,152,184
4,289,908
4,162,799
4,287,221
4,379,498
4,357,583
6,310,671
6,277,097
6,329,238
6,529,954
6,747,588
6,761,963
6,667,550
6,701,236
7,035,514
6,832,734
6,832,7347,035,5146,701,2366,667,5506,761,9636,747,5886,529,9546,329,2386,277,0976,310,6714,357,5834,379,4984,287,2214,162,7994,289,9084,152,1844,122,5113,688,0593,487,1503,366,5453,377,8933,251,5853,046,1752,936,1042,832,7053,026,3452,930,8272,044,6701,959,9871,963,7241,850,3912,175,5402,283,1862,297,5152,218,4452,142,0072,098,3111,033,539967,916918,653916,459809,807649,087
   Common Stock
200,000
200,000
0
200,000
200,000
200,000
267,000
267,000
267,000
267,000
267,000
267,000
267,000
267,000
267,000
267,000
284,945
284,945
284,945
284,945
284,945
286,556
286,556
286,556
286,688
286,597
292,000
408,732
408,732
408,732
408,674
408,674
408,674
448,601
582,345
584,903
584,903
584,903
584,807
0
0
0
0
0000584,807584,903584,903584,903582,345448,601408,674408,674408,674408,732408,732408,732292,000286,597286,688286,556286,556286,556284,945284,945284,945284,945284,945267,000267,000267,000267,000267,000267,000267,000267,000267,000267,000200,000200,000200,0000200,000200,000
   Retained Earnings 
288,079
444,880
0
564,295
625,832
691,455
746,199
789,895
866,333
945,403
931,074
994,485
1,021,961
1,135,294
1,131,558
1,216,241
1,312,661
1,442,619
1,248,980
1,352,379
1,462,752
1,513,046
1,625,753
1,606,380
1,825,052
2,021,433
2,161,332
2,186,615
2,323,573
2,455,864
2,576,765
2,621,931
2,739,370
2,981,274
2,971,892
3,125,014
3,095,991
3,531,985
3,563,695
3,263,262
3,687,106
4,008,343
3,803,825
3,803,8254,008,3433,687,1063,263,2623,563,6953,531,9853,095,9913,125,0142,971,8922,981,2742,739,3702,621,9312,576,7652,455,8642,323,5732,186,6152,161,3322,021,4331,825,0521,606,3801,625,7531,513,0461,462,7521,352,3791,248,9801,442,6191,312,6611,216,2411,131,5581,135,2941,021,961994,485931,074945,403866,333789,895746,199691,455625,832564,2950444,880288,079
   Capital Surplus 0000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,524
56,524
56,504
56,482
0
0
0
0
0
0
84,206
82,127
57,935
24,986
0
32,536
11,244
0
0
0
0
000011,24432,536024,98657,93582,12784,20600000056,48256,50456,52456,5240000000000000000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue22,437,489
Cost of Revenue-15,134,227
Gross Profit7,303,2627,303,262
 
Operating Income (+$)
Gross Profit7,303,262
Operating Expense-20,899,126
Operating Income1,538,363-13,595,864
 
Operating Expense (+$)
Research Development2,511
Selling General Administrative4,914,501
Selling And Marketing Expenses0
Operating Expense20,899,1264,917,011
 
Net Interest Income (+$)
Interest Income27,706
Interest Expense-185,604
Other Finance Cost-14,283
Net Interest Income-172,181
 
Pretax Income (+$)
Operating Income1,538,363
Net Interest Income-172,181
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,407,8331,538,363
EBIT - interestExpense = -185,604
929,023
1,114,628
Interest Expense185,604
Earnings Before Interest and Taxes (EBIT)01,593,438
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,407,833
Tax Provision-284,274
Net Income From Continuing Ops1,123,5591,123,559
Net Income929,023
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0172,181
 

Technical Analysis of Laobaixing Pharmacy
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Laobaixing Pharmacy. The general trend of Laobaixing Pharmacy is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Laobaixing Pharmacy's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Laobaixing Pharmacy.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 22.81 < 26.16 < 27.85.

The bearish price targets are: 19.71 > 18.75 > 15.39.

Tweet this
Laobaixing Pharmacy Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Laobaixing Pharmacy. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Laobaixing Pharmacy Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Laobaixing Pharmacy. The current macd is 1.07851752.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Laobaixing Pharmacy price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Laobaixing Pharmacy. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Laobaixing Pharmacy price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Laobaixing Pharmacy Daily Moving Average Convergence/Divergence (MACD) ChartLaobaixing Pharmacy Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Laobaixing Pharmacy. The current adx is 30.46.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Laobaixing Pharmacy shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Laobaixing Pharmacy Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Laobaixing Pharmacy. The current sar is 16.07.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Laobaixing Pharmacy Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Laobaixing Pharmacy. The current rsi is 71.78. The current phase is Overbought in neutral market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Overbought in neutral market:
  • Trending up: The RSI is trending up. +1
Laobaixing Pharmacy Daily Relative Strength Index (RSI) ChartLaobaixing Pharmacy Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Laobaixing Pharmacy. The current phase is Overbought in neutral market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Laobaixing Pharmacy price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Laobaixing Pharmacy Daily Stochastic Oscillator ChartLaobaixing Pharmacy Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Laobaixing Pharmacy. The current cci is 217.94.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Laobaixing Pharmacy Daily Commodity Channel Index (CCI) ChartLaobaixing Pharmacy Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Laobaixing Pharmacy. The current cmo is 57.94.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Laobaixing Pharmacy Daily Chande Momentum Oscillator (CMO) ChartLaobaixing Pharmacy Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Laobaixing Pharmacy. The current willr is -15.03267974.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Laobaixing Pharmacy Daily Williams %R ChartLaobaixing Pharmacy Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Laobaixing Pharmacy.

Laobaixing Pharmacy Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Laobaixing Pharmacy. The current atr is 1.20074729.

Laobaixing Pharmacy Daily Average True Range (ATR) ChartLaobaixing Pharmacy Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Laobaixing Pharmacy. The current obv is 288,819,551.

Laobaixing Pharmacy Daily On-Balance Volume (OBV) ChartLaobaixing Pharmacy Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Laobaixing Pharmacy. The current mfi is 88.58.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Laobaixing Pharmacy Daily Money Flow Index (MFI) ChartLaobaixing Pharmacy Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Laobaixing Pharmacy.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Laobaixing Pharmacy Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Laobaixing Pharmacy based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5071.781
Ma 20Greater thanMa 5017.130
Ma 50Greater thanMa 10015.620
Ma 100Greater thanMa 20016.771
OpenGreater thanClose19.800
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Laobaixing Pharmacy with someone you think should read this too:
  • Are you bullish or bearish on Laobaixing Pharmacy? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Laobaixing Pharmacy? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Laobaixing Pharmacy

I send you an email if I find something interesting about Laobaixing Pharmacy.


Comments

How you think about this?

Leave a comment

Stay informed about Laobaixing Pharmacy.

Receive notifications about Laobaixing Pharmacy in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.